Relationship between Binet staging, mutational status of Ig genes and expression of ZAP-70, lipoprotein lipase (LPL) and ADAM-29 genes.
| . | VHMUT . | VHUNM . | ZAP-70− . | ZAP-70+ . | LPL+ . | ADAM 29+ . |
|---|---|---|---|---|---|---|
| * Due to the relatively short follow-up in these series and the small number of events overall survival could not be performed for ZAP-70, LPL and ADAM-29 expression among stage A patients. | ||||||
| Abbreviations: OS, overall survival; PFS, progression-free survival | ||||||
| Stage A | ||||||
| % | 69 | 31 | 65 | 35 | 31 | 69 |
| OS, mo.* | NA | 87 | ||||
| PFS, mo. | 156 | 42 | NA | 29 | 87 | NA |
| Stages B+C | ||||||
| % | 35 | 65 | 31 | 69 | 61 | 39 |
| OS, mo. | 120 | 78 | 100 | 80 | 65 | 100 |
| . | VHMUT . | VHUNM . | ZAP-70− . | ZAP-70+ . | LPL+ . | ADAM 29+ . |
|---|---|---|---|---|---|---|
| * Due to the relatively short follow-up in these series and the small number of events overall survival could not be performed for ZAP-70, LPL and ADAM-29 expression among stage A patients. | ||||||
| Abbreviations: OS, overall survival; PFS, progression-free survival | ||||||
| Stage A | ||||||
| % | 69 | 31 | 65 | 35 | 31 | 69 |
| OS, mo.* | NA | 87 | ||||
| PFS, mo. | 156 | 42 | NA | 29 | 87 | NA |
| Stages B+C | ||||||
| % | 35 | 65 | 31 | 69 | 61 | 39 |
| OS, mo. | 120 | 78 | 100 | 80 | 65 | 100 |